Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesEstimating Drug Costs in Economic Evaluations in Ireland and the UK: An Analysis of Practice and Research Recommendations
PharmacoEconomics, 09/02/09
Hughes DA et al. – The authors reviewed recent pharmacoeconomic evaluations undertaken in Ireland and the UK and documented the sources of data for drug costs and the methods of cost estimation. Methods were often inadequately described and, where adequate information was available, there was considerable variation and limitations in the methods used, thereby reducing the comparability of studies.
Related Articles
Economic Evaluation of Pharmacotherapy of Migraine Pain: A Review of the Literature
Journal Of Pain & Palliative Care Pharmacotherapy, 12/02/09
Relevance Score: 92%%
Impact of the Economic Crisis and Increase in Food Prices on Child Mortality: Exploring Nutritional Pathways
The Journal of Nutrition, 11/20/09
Relevance Score: 87%%
New Report Details Impact of Economic Downturn on Patients and Hospitals
AMN Healthcare, 11/20/09
Relevance Score: 87%%
Designing attractive health care spaces on a budget
Health Facilities Management, 11/19/09
Relevance Score: 87%%
Organizational changes at AHA
American Hospital Association News, 11/12/09
Relevance Score: 87%%
Today in Pharmacoeconomics...keeping you current
Receive free subspecialty "5-minute updates" via email
Economic Evaluation of Pharmacotherapy of Migraine Pain: A Review of the Literature
Journal Of Pain & Palliative Care Pharmacotherapy, 12/02/09
Imipenem Resistance in Pseudomonas aeruginosa: Emergence, Epidemiology, and Impact on Clinical and Economic Outcomes
Infection Control and Hospital Epidemiology, 12/02/09
Healthcare Costs and Obesity Prevention: Drug Costs and Other Sector-Specific Consequences
PharmacoEconomics, 11/30/09
Sponsor
Article Search
Sponsor